Berlin, Germany

Antonius Ter Laak

This inventor holds 12 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Aktiengesellschaft, Bayer Schering Pharma Ag. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonius Ter Laak. Retrieved from https://idiyas.com/inventor/antonius-ter-laak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 41.7

 

 

Average Co-Inventor Count = 9.1

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2010-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Furoindazole Derivatives
Acyl Sulfonamides
Benzimidazole Derivatives
ATAD2 Inhibitors
Aryl-Cyanoguanidine Compounds
Pyrazolopyridines
Pharmaceutical Composition
Protein Tyrosine Kinases
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Antonius Ter Laak

Introduction

Antonius Ter Laak is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 11 patents to his name, Ter Laak's work has the potential to impact the medical community profoundly.

Latest Patents

One of his latest patents involves acyl sulfonamides for treating cancer. This invention provides acyl sulfonamide compounds of general formula (I): 4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides. The patent covers these compounds, methods of preparing them, and their use in pharmaceutical compositions for the treatment or prophylaxis of diseases, particularly cancer. This innovation highlights Ter Laak's commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Antonius Ter Laak has worked with prominent companies in the pharmaceutical industry, including Bayer Pharma Aktiengesellschaft and Bayer Schering Pharma AG. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical treatments.

Collaborations

Ter Laak has collaborated with notable colleagues, including Roman Hillig and Nico Bräuer. These partnerships have likely facilitated the exchange of ideas and expertise, further enhancing the quality and impact of his inventions.

Conclusion

Antonius Ter Laak's contributions to the field of pharmaceuticals, particularly in cancer treatment, demonstrate his innovative spirit and dedication to improving healthcare. His patents and collaborations reflect a commitment to advancing medical science, making him a significant figure in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…